Aurinia yesterday announced the FDA that the has approved voclosporin (Lupkynis) for Lupus Nephritis. Voclosporin is an oral calcineurin inhibitor to be used in combination with a background immunosuppressives to treat adultswith active lupus nephritis https://t.co/90ba2Iq0eU